CD8A and hepatocellular carcinoma: M2-derived EVs enable HCC to decrease MISP and promote the nuclear translocation of IQGAP1, which activates STAT3 phosphorylation and augments the expression of its downstream PD-L1, thereby modulating CD8+ T cell apoptosis and impairing their cytotoxic killing capacity[39].